−0.010 CAD
−779.81 K CAD
532.00 K CAD
89.80 M
About PHARMALA BIOTECH HOLDINGS INC.
PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MDMA is 0.295 CAD — it has decreased by −3.33% in the past 24 hours. Watch PHARMALA BIOTECH HOLDINGS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange PHARMALA BIOTECH HOLDINGS INC. stocks are traded under the ticker MDMA.
MDMA stock has fallen by −12.12% compared to the previous week, the month change is a 61.11% rise, over the last year PHARMALA BIOTECH HOLDINGS INC. has showed a 227.78% increase.
MDMA reached its all-time high on May 2, 2023 with the price of 0.540 CAD, and its all-time low was 0.020 CAD and was reached on May 11, 2022. View more price dynamics on MDMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MDMA stock is 5.26% volatile and has beta coefficient of 2.56. Track PHARMALA BIOTECH HOLDINGS INC. stock price on the chart and check out the list of the most volatile stocks — is PHARMALA BIOTECH HOLDINGS INC. there?
Yes, you can track PHARMALA BIOTECH HOLDINGS INC. financials in yearly and quarterly reports right on TradingView.
MDMA net income for the last quarter is −413.15 K CAD, while the quarter before that showed −222.57 K CAD of net income which accounts for −85.63% change. Track more PHARMALA BIOTECH HOLDINGS INC. financial stats to get the full picture.
No, MDMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMALA BIOTECH HOLDINGS INC. EBITDA is −496.09 K CAD, and current EBITDA margin is −136.66%. See more stats in PHARMALA BIOTECH HOLDINGS INC. financial statements.
Like other stocks, MDMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMALA BIOTECH HOLDINGS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMALA BIOTECH HOLDINGS INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMALA BIOTECH HOLDINGS INC. stock shows the buy signal. See more of PHARMALA BIOTECH HOLDINGS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.